Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms

Personalized healthcare company Accolade Inc (NASDAQ:ACCD) stock is trading slightly higher after the company announced fiscal second quarter 2025 results.

The company reported a revenue increase of 10% to $106.36 million, beating the consensus of $105.01 million. Loss per share of $0.30 beat the consensus loss of $0.44.

Adjusted gross profit rose 17% Y/Y to $50.30 million. Adjusted EBITDA loss narrowed ...